Cargando…
Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer
BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored. Previous findings sug...
Autores principales: | Hazlett, Jody, Niemi, Virginia, Aiderus, Aziz, Powell, Katelyn, Wise, Lyn, Kemp, Roslyn, Dunbier, Anita K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489094/ https://www.ncbi.nlm.nih.gov/pubmed/34602068 http://dx.doi.org/10.1186/s13058-021-01472-1 |
Ejemplares similares
-
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
por: Ribas, Ricardo, et al.
Publicado: (2014) -
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
por: Gellert, Pascal, et al.
Publicado: (2016) -
Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016) -
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation.
por: Pink, J. J., et al.
Publicado: (1996) -
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
por: Borley, Annabel C, et al.
Publicado: (2008)